BioSpace News Archive

LetsGetChecked recognized for achievements in home health testing

CareDx and American Association of Kidney Patients collaboration reveal key patient insights

NarxCare – Created by Appriss Health – will Help Rite Aid Pharmacists More Efficiently and Effectively Identify and Manage Patients at Risk for Controlled Substance Misuse and Abuse

Geneoscopy, Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, today announced a successful and oversubscribed $6.9 million Series A financing

Rising Pharma Holdings Inc. (“Rising Pharmaceuticals”), today announced the U.S. launch & commercialization of six new generic products during the third quarter 2019.

Parent Project Muscular Dystrophy, a nonprofit organization leading the fight to end Duchenne muscular dystrophy, and Duchenne UK announced the joint funding of a project to create a set of agreed and validated Patient Reported Outcomes for use in Europe and the US.

Point-of-care testing is transforming healthcare: this type of testing helps patients get diagnosed and treated faster, and also makes it easier for patients in remote areas to have access to medical testing

Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antibiotic resistance, today announced that it met its first milestone three months ahead of schedule for the milestone-based contract worth up to $45 million from the Biomedical and Advanced Research Authority (BARDA), a division of the U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR).

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced two poster presentations at the 24th Annual International Congress of the World Muscle Society (WMS).

Agilent Technologies Inc. (NYSE: A) today announced that the National Medical Products Administration (NMPA, formerly the China Food and Drug Administration) has approved its PD-L1 IHC 22C3 pharmDx assay for use in China.